The device for detection of cancer on a blood drop

2019: Announcement

At the end of November, 2019 the Toshiba corporation stated that it developed technology of detection of 13 types of cancer on one drops of blood. Accuracy of a new technique, according to developers, reaches 99%. It already began to be applied in clinical practice.

Toshiba developed a new method of diagnostics together with Research institute of the National oncological center and the Tokyo medical university. The corporation hopes to commercialize a new technique in the form of the convenient device in "several years". However at first the method should pass clinical trials which are appointed to 2020.

Toshiba stated that it developed technology of detection of 13 types of cancer on one drops of blood

According to developers, this method can be used for detection of cancer at the earliest stages. The method allows to reveal the molecules microrNA selected in blood from cancer cells and also to define their concentration. It should be noted that it is not a new technique — Toray Industries Inc. and other companies also develop technologies for diagnosis of cancer which are based on detection of molecules microrNA in the analysis of a blood sample.

In comparison with methods of other companies we have an important advantage - we provide higher accuracy of diagnosis of cancer for shorter term and for much smaller cost, - the chief specialist of research laboratory Toshiba Frontier Research Laboratory which is engaged in development of a new technique noted on Koji Hashimoto press release.

The technique will be used for detection of cancer of stomach, a gullet, lungs, a liver, biliary tract, a pancreas, intestines, ovaries, a prostate, a bladder and a mammary gland and also for detection of sarcomas and gliomas. Toshiba developed the chip and the small device which can carry out diagnostics less than in two hours at  the cost of analysis of 20,000 yens ($180) or is cheaper.^[1]

Notes